Evercore ISI Group Maintains Outperform on Twist Bioscience, Raises Price Target to $56

Benzinga Newsdesk www.benzinga.com Positive 90.4%

Neg 0% Neu 0% Pos 90.4%

Evercore ISI Group analyst Vijay Kumar maintains Twist Bioscience (NASDAQ:TWST) with a Outperform and raises the price target from $52 to $56.